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There is evidence from histopathological studies that glioma tumor cells migrate
preferentially along large white matter bundles. If the peritumoral white matter structures
can be used to predict the likely trajectory of migrating tumor cells outside of the surgical
margin, then this information could be used to inform the delineation of radiation therapy
(RT) targets. In theory, an anisotropic expansion that takes large white matter bundle
anatomy into account may maximize the chances of treating migrating cancer cells
and minimize the amount of brain tissue exposed to high doses of ionizing radiation.
Diffusion-weighted MRI (DW-MRI) can be used in combination with fiber tracking
algorithms to model the trajectory of large white matter pathways using the direction
and magnitude of water movement in tissue. The method presented here is a tool for
translating a DW-MRI fiber tracking (tractography) dataset into a white matter path length
(WMPL) map that assigns each voxel the shortest distance along a streamline back to a
specified region of interest (ROI). We present an open-source WMPL tool, implemented
in the package Diffusion Imaging in Python (DIPY), and code to convert the resulting
WMPL map to anisotropic contours for RT in a commercial treatment planning system.
This proof-of-concept lays the groundwork for future studies to evaluate the clinical value
of incorporating tractography modeling into treatment planning.
Keywords: tractography, glioma, code:Python, neuro oncology, radiation therapy (radiotherapy), diffusion MRI
(dMRI)
INTRODUCTION
Tumors which originate from glial cells are known as gliomas, which are the most common form
of malignant primary brain tumor. Glioblastoma is the highest grade and most aggressive variant
of glioma. The treatment for glioblastoma typically consists of surgery, radiation therapy, and
chemotherapy, but the prognosis for patients is still quite poor with a median survival of about
15 months (1).
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The standard treatment starts with a maximal safe
neurosurgical resection (2). After surgery, the patient
typically receives concurrent radiation therapy (RT) and
chemotherapy (3). Postmortem investigation has suggested that
most recurrences (90%) occur within 2 cm of the primary tumor
site (4), so the RT treatment volume (Clinical Target Volume
= CTV) is often defined by an isotropic expansion of 1.5–2 cm
around the combined tumor bed and any residual tumor (Gross
Tumor Volume = GTV). The goal of the CTV expansion is to
irradiate infiltrating microscopic disease not visible by standard
anatomic imaging in an attempt to reduce tumor recurrence.
It should be noted that there is not a consensus on the optimal
way to define the CTV. Several studies have tested the accuracy
of different RT volume definitions. In a study by Hess et al.,
the CTV was defined as an isotropic 2 cm expansion, and 86%
of recurrences occurred within the treated volume (5). Studies
reducing the isotropic expansion to 0.5–1.0 cm around the
tumor bed continue to show 80–90% of recurrences within the
treated volume (6–8). Another study by Chang et al. investigated
whether inclusion of peritumoral edema as defined by T2-
weighed MRI abnormality improved target coverage. Whether
or not peritumoral edema was included, 10% of patients recurred
outside the target volume, although covering peritumoral edema
increased the volume of normal brain receiving radiation (9).
These studies suggest that for the majority of patients, treatment
volumes could be safely reduced without compromising tumor
control. Conversely, for a minority of patients with marginal
or out-of-field recurrences, further target expansion may have
improved tumor control. In both cases, however, isotropic
expansion from the tumor bed is likely an oversimplification of
the disease biology and recurrence risk pattern.
There is evidence that glioma cells migrate preferentially along
large white matter bundles (10–13), so an anisotropic expansion
that takes large white matter bundle configuration into account
may maximize the chances of radiating migrating cancer cells
and minimize the amount of brain tissue radiated. Diffusion-
weighted MRI (DW-MRI) can be used in combination with fiber
tracking algorithms to model the trajectory of large white matter
pathways using the direction and magnitude of water movement
in tissue (14–24).
In light of this potential for using DW-MRI to tailor the
CTV, several pilot studies have been conducted by researchers
seeking to leverage this phenomenon. Berberat et al. found that
incorporating diffusion tensor imaging (DTI) into the planning
trended toward reduction in CTV volume and still included
tumor recurrence sites (25). Kallehauge et al. piloted a DTI
driven growth model to similarly adapt the CTV and found
that irregular shapes with higher surface area were produced,
compared to a more standard CTV, with a dice similarity
coefficient of just over 0.7 (26, 27). Jbabdi et al. developed a
computational model of brain tumor growth and found that
simulation of low-grade glioma growth was improved when
anisotropic diffusion was introduced using DTI (28). These
studies approach the challenge of leveraging DW-MRI to predict
recurrence without a unifying framework to compare and build
off of each other’s models, indicating that developing a tool for
executing these studies would be valuable to the field.
The method presented here is a versatile tool for translating
a diffusion MRI (dMRI) fiber tracking (tractography) dataset
into a white matter path length (WMPL) map that assigns
each voxel the shortest distance along a streamline back to a
specified region of interest (ROI). This approach is agnostic to
tractography algorithm, enabling the user to test any model that
produces streamlines, and can be used to anisotropically modify
RT contours. This opens the door for studies that explore models
from a simple tensor (DTI) to models that take advantage of high
angular resolution diffusion imaging (HARDI) and multi-shell
acquisitions. The code was implemented in theDiffusion Imaging
in Python (DIPY) package (29) so it interfaces easily with other
DIPY tools and can be modified to add new functionality by
contributing to this open-source project (dipy.org). This proof-
of-concept lays the groundwork for future studies to evaluate
the clinical value of incorporating tractography modeling into
treatment planning tomore specifically target tumor cells that are
theoretically migrating along white matter pathways.
CODE
White Matter Path Length Function
The path_length function (Appendix 1 in
Supplementary Material), implemented in python as part
of the Diffusion Imaging in Python (DIPY) open-source package
(29) (PR 1114) computes the shortest path, along any streamline,
between a given region-of-interest (ROI) and each voxel in the
specified ROI.
Other supporting functions included in this Pull Request
(PR 1114: flexi_tvis_affine, get_flexi_tvis_affine) are used in the
path_length function to reconcile affine transformations to map
between grid and streamline spaces with different voxel orders.
These functions are useful in other applications, like targeting
streamlines with an ROI and creating VTK renders.
A demonstration of the path_length function can be found in
Appendix 2 in Supplementary Material. The input is a dataset
of streamlines in the Trackvis file format (Ruopeng Wang, Van J.
Wedeen, TrackVis.org, Martinos Center for Biomedical Imaging,
Massachusetts General Hospital) and a region-of-interest in the
nifti file format. The mapping from voxel indices to streamline
points (affine transformation) is calculated using the function
get_flexi_tvis_affine, which inputs the header from the trackvis
file and the affine from the nifti file, and outputs a 4 × 4
array. A tutorial is available in the gallery section of the DIPY
website (dipy.org).
The output of this white matter path_length function (WMPL
map) is an array with each voxel representing the shortest
streamline distance back to the given ROI, with voxels not
intersected by a streamline set at a filler value (default = −1).
The output can be saved in the nifti file format, as demonstrated
in Appendix 2 in Supplementary Material. ThisWMPLmap can
then be input to a Raystation python script written specifically for
translating the path length map to radiation therapy contours in
the TPS (Appendix 3 in Supplementary Material),. The WMPL
map could be used to generate contours for use with other
TP systems, but this would require writing new anisotropic
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expansion code to translate the WMPL map into contours
compatible with other systems.
Raystation Contour Calculation
The WMPL maps were imported in the treatment planning
system (TPS) (RayStation V5.0.2, RaySearch Laboratories,
Stockholm, Sweden) in the same frame of reference as the
diffusion weighted MR scan. The planning CT scan was rigidly
registered to all MR scans (diffusion, T1 post gad, and FLAIR)
for creation and transfer of new contours. A python script
was created in the TPS to automate the creation of multiple
CTVdwMRI ROIs using intensity thresholding of selected
expansion path length (EPL) on the WMPL maps. Boolean
operations were then applied in order to create CTVdwMRI
volumes that excluded any tissue outside the brain. The
CTVdwMRI contours consisted of the union of the GTVwith the
WMPLmaps for EPL values of 1, 2, and 3 cm. A 5mm expansion
was finally applied to the results of the union to limit the
formation of small contour islands. In total, each patient included
in this study had an isotropic 2 cm expansion CTVisotropic
around the GTV and 3 anisotropic expansions for each EPL value
tested (CTVdwMRI for 1, 2, and 3 cm).
METHODS
Patients
Thirteen patients with newly diagnosed glioblastoma treated
with radiotherapy at the University of California, San Francisco
between 2011 and 2015 were selected retrospectively based
on the following inclusion criteria. Patients selected were
treated with radiotherapy to a dose of 60Gy in standard
fractionation with concurrent temozolomide, underwent High
Angular Resolution Diffusion Imaging (HARDI) with the
specified parameters (below), underwent regular surveillance
MRI (2 month intervals) at UCSF, and had radiographically
confirmed recurrence. Nine patients were excluded because they
did not have a radiographically confirmed non-disseminated
recurrence. All included subjects underwent a HARDI with the
following parameters: 55 directions, b = 1,000 s/mm2, 1 B0
image, 1.09× 1.09mm in-plane resolution, 2mm slice thickness.
Institutional Review Board approval was obtained by the UCSF
Committee on Human Research for retrospective analysis of
imaging of de-identified patients receiving standard of care for
treatment of primary glioblastoma.
Approach
Given the evidence from pathology studies that glioma cells
preferentially migrate along large white matter bundles (10,
11), the use of tractography information to model the
trajectory of these pathways should increase the chance that
a radiation therapy (RT) treatment volume includes the site
of future recurrence. To incorporate the diffusion tractography
information into the RT treatment planning software, a path
length map was generated to represent the modeled white matter
pathway distance. Each voxel was assigned the value of the
minimum distance along a streamline connecting it to the Gross
Tumor Volume (GTV), defined as the union of the resection
cavity and any residual tumor. A radiation oncologist hand-
drew each GTV to include the resection cavity and any residual
disease, using the T1-weighted post-contrast and T2-weighted
FLAIR images.
RADIATION THERAPY PLANNING
Target Delineation
The GTV was obtained from manual delineation of the post-
surgical tumor bed and enhancing regions on post-operative
T1-weighted post-contrast MRI. Abnormal mass-like non-
enhancing T2-weighted FLAIR signal was also considered
for delineation of the GTV. All patients were treated with
conventionally defined target volumes, with the clinical target
volume generated from 1.5 to 2.0 cm, largely isotropic, expansion
of the GTV. A planning target volume (PTV) was generated from
0.3 to 0.5 cm expansion of the CTV. PTV was prescribed 60Gy
with an objective of 95% target coverage. On post-treatment
surveillance images showing tumor recurrence/progression,
recurrent tumor volumes were also hand-drawn for comparison
to original radiation targets.
Calculation of White Matter Path Length
Residual Bootstrap Q-ball Tractography (30) was performed
by seeding all voxels with a fractional anisotropy (FA) >0.15.
The tracking was performed at a density of one seed per voxel
with the parameters described in Bucci et al. Tracking was
terminated by the following stopping criteria: an FA threshold
of 0.15 or maximum angle of 60 degrees. The GTV was targeted
from this whole-brain streamline dataset to select the subset
of streamlines modeling the white matter architecture around
the tumor. For visualization purposes, all figures showing GTV-
connected streamlines were filtered to remove outliers using
the Cluster Confidence Index (CCI > 1; default parameters;
implemented in DIPY) (31). The GTV-connected streamlines
were converted into a three-dimensional (3D) map, with the
value of each voxel representing the minimum white matter
path length (WMPL) between the voxel and the GTV. The path
length function, implemented in the DIPY open-source package
(https://github.com/nipy/dipy/pull/1114), computes the shortest
path along any streamline between a given ROI and each voxel
in the brain. Each voxel of the WMPL map conveys the shortest
distance (in mm) from low to high back to the GTV along a white
matter streamline. See Appendix 1 in Supplementary Material
for code.
Creation of the CTV Volumes
The WMPL maps were imported in the treatment planning
system (TPS) (RayStation V5.0.2, RaySearch Laboratories,
Stockholm, Sweden) in the same frame of reference as the
diffusion weighted MR scan. The planning CT scan was rigidly
registered to all MR sequences for creation and transfer of new
contours. A Python script was written in the TPS to automate
the creation of multiple CTVdwMRI volumes using gray-level
thresholding of selected expansion path length (EPL) on the
WMPL maps. Boolean operations were then applied in order to
create CTVdwMRI volumes that excluded any tissue outside the
brain. The CTVdwMRI contours consisted of the union of the
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FIGURE 1 | Patient 1 Fiber Tracking Model of GTV White Matter Connectivity: the streamline connectivity of the GTV (red volume) is shown with the recurrence ROI
(yellow volume) in the top panels. The bottom panels show the Arcuate Fascicle isolated from the streamline connectivity of the GTV (red volume), it is apparent that
the recurrence (yellow volume) follows the path of the bundle modeled using tractography.
FIGURE 2 | Patient 1 WMPL Map from GTV: The White Matter Path Length (WMPL) map was generated based on the streamline dataset from the GTV. The WMPL
shows the distance along streamlines from the GTV from low (dark blue) to high (light blue) distance. The GTV is shown in red.
GTV with the WMPL maps for EPL values of 1, 2, and 3 cm. A
5mm expansion was finally applied to the results of the union
to limit the formation of small contour islands. In total, each
patient included in this study had an isotropic 2 cm expansion
CTVisotropic around the GTV and three anisotropic expansions
for each EPL value tested (CTVdwMRI for 1, 2, and 3 cm). See
Appendix 3 in Supplementary Material for code.
RESULTS
The phenomenon of recurrent tumor cells spreading
preferentially along white matter pathways was demonstrated
by several cases in this cohort. In Patient 1 (Figure 1), the
GTV is shown in red with the recurrence shown in yellow.
The tractography white matter model of GTV-connected
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FIGURE 3 | Patient 2 Fiber Tracking Model of GTV White Matter Connectivity: the streamline connectivity of the GTV (red volume) is shown with the recurrence ROI
(yellow volume), which appears to follow the path of the cingulum bundle.
FIGURE 4 | Patient 2 WMPL map from GTV: the White Matter Path Length (WMPL) map was generated based on the streamline dataset from the GTV. The WMPL
shows the distance along streamlines from the GTV from low (dark blue) to high (light blue) distance. The GTV is shown in red.
streamlines shows the Arcuate Fascicle, the Inferior Fronto-
Occipital Fascicle (IFOF), the Inferior Longitudinal Fascicle
(ILF), and the corpus callosum (CC) connected to the GTV. The
recurrence appears to be following the trajectory of the Arcuate
Fascicle, visible on the 180 degree Z-rotation in Figure 1.
The WMPL map (Figure 2) converts the tractogram into a
format that can be converted into RT treatment contours.
In Patient 2 (Figure 3), the GTV is shown in red with the
recurrence shown in yellow. The tractography white matter
model of GTV-connected streamlines shows the Cingulum
Bundle connected to the GTV. The recurrence appears to
be following the trajectory of the Cingulum Bundle. The
WMPL map for Patient 2 is shown in Figure 4, and the
corresponding anisotropic RT contour planning generated
from this WMPL is shown in Figure 5. Code for generating
the WMPL map and subsequently anisotropic RT contours
in the commercial RT treatment planning system RayStation
(RaySearch Laboratories, Stockholm, Sweden) can be found in
the Appendix in Supplementary Material.
DISCUSSION
These WMPL maps can be loaded into an RT planning software
to anisotropically modify the treatment volume. An example
case is shown in Figure 5. The WMPL map (orange) was
used to anisotropically expand the GTV (red) to generate the
anisotropic CTV (pink). Compared to the isotropic CTV (green),
the anisotropic CTV (pink) better matches the eventual location
of recurrence (yellow). This suggests that, in this case, tissue
at high risk of subclinical disease could have been predicted
by probing the white matter architecture. This procedure was
performed on all patients in the pilot cohort that met inclusion
criteria to evaluate the clinical application through accuracy
and volume of tissue radiated. Results from the retrospective
cohort study will be reported elsewhere. Briefly, of 13 cases, three
had marginal recurrences using a standard isotropic technique.
Using WMPL to define target volumes, two of three marginal
recurrences would have been included in the target volume, and
all other recurrences would have remained within the target
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FIGURE 5 | Patient 2 Raystation Treatment Planning Software Anisotropic CTV Based on WMPL Map: this figure (BOTTOM) shows the White Matter Path Length
(WMPL) map generated based on the streamline dataset from the GTV and GTV ROI and imported into Raystation (orange). The GTV (red) is expanded anisotropically
using the pathlength map (pink), which follows the path of the recurrence (yellow). In the TOP RIGHT figure, the 2 cm anisotropic CTV (pink) follows the path of the
recurrence (yellow) better than the 2 cm isotropic CTV (green). In the TOP LEFT figure, the corresponding 3D rendering of the GTV-connected streamlines and the
recurrence ROI (yellow) are shown.
volume. This improved recurrence coverage was accomplished
with median 19% smaller target volume than the isotropic
technique (range [−34%,+10%]). These pilot results suggest that
incorporating white matter microstructure, modeled using dMRI
tractography, is a promising approach to predict regions of out-
of-field recurrence and reduce tissue at a low risk for subclinical
disease. These preliminary results suggest the approach warrants
further study to establish sensitivity and specificitymeasurements
in a larger cohort with more marginal and distant recurrences.
The demonstrated evaluation of a diffusion approach is a
good method to quickly evaluate whether or not an anisotropic
expansion confers added benefit to standard-of-care isotropic
expansion. If the anisotropic expansion provided by the
underlying streamline maps adds value to the prediction of
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recurrence, the volume of the anisotropic expansion should
be less than that of the isotropic recurrence when both are
expanded to the recurrence site in a cohort of patients.
After added-value has been established, then a much larger
study should be conducted to set expansion parameters
so that the methodology can be tested prospectively in a
clinical trial.
The flexibility of this approach enables any number of
studies to be conducted to investigate the best way to
incorporate diffusion information into Radiation Therapy
planning. The provided code works on a set of streamlines,
so many types of tractography could be investigated, in
addition to methods that incorporate human-operator quality-
control steps. The target ROI can also be varied to investigate
integrating pathway distance from residual tumor, the primary
tumor site, or edematous tissue. The timepoint at which
the DW-MRI data is collected could also be varied. This
pilot was performed using post-surgical pre-radiation therapy
HARDI datasets, but pre-surgical HARDI datasets might
be more effective to study because the fascicles underlying
the tractography have not yet been disturbed by surgical
intervention. Many theories of how to use pathway information
can be tested with this methodology: for example, large
bundles that were cut by the surgery could be isolated to see
if neuronal degeneration creates a tumorigenic environment,
increasing the chance that the tumor will recur along that
pathway. If a set of streamlines can be created to reflect a
hypothesis, this framework easily translates the dataset into
an added-value analysis to evaluate whether or not that
streamline dataset improved prediction of recurrence over
isotropic expansion.
CONCLUSIONS
This proof-of-concept demonstrated a tool for integrating
diffusion information with existing protocols for Radiation
Therapy Planning. The WMPL maps presented in this
manuscript can be used to conduct studies predicting
tumor recurrence using diffusion data to model white
matter architecture. The code to generate the WMPL maps
is open-source and freely available on Github as part of
the Diffusion Imaging in Python package (29). We have
piloted this methodology retrospectively in a cohort of
patients that will be reported on elsewhere. We hope that
this methodology facilitates investigation of the hypothesis
that modifying the CTV based on diffusion models of white
matter architecture results in treatment plans that maximize
radiation of tissue at high risk for subclinical disease and/or
minimize radiation of tissue at low risk for subclinical disease.
This proof-of-concept lays the groundwork for future studies
to evaluate the clinical value of incorporating tractography
modeling into treatment planning to more specifically target
tumor cells that are theoretically migrating along white
matter pathways.
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